Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Sep;43(3):434-41.
doi: 10.1016/j.jhep.2005.03.019.

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial

Adrian M Di Bisceglie  1 , Richard K Sterling, Raymond T Chung, James E Everhart, Jules L Dienstag, Herbert L Bonkovsky, Elizabeth C Wright, Gregory T Everson, Karen L Lindsay, Anna S F Lok, William M Lee, Timothy R Morgan, Marc G Ghany, David R Gretch; HALT-C Trial Group
Affiliations
Clinical Trial

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial

Adrian M Di Bisceglie et al. J Hepatol. 2005 Sep.

Abstract

Background/aims: Alpha-fetoprotein (AFP) has been useful in the diagnosis of hepatocellular carcinoma (HCC) but lacks specificity. We assessed serum AFP among patients with chronic hepatitis C and advanced fibrosis to establish predictors of AFP elevations and changes with antiviral therapy.

Methods: Serum AFP was measured at baseline and on therapy in patients in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C). AFP levels were correlated with patient demographic and clinical features.

Results: Baseline AFP was > or = 20 ng/mL in 191 of 1145 patients (16.6%). Mean AFP values were significantly higher in patients with cirrhosis than in those with bridging fibrosis (22.5 vs. 11.4 ng/mL, P < 0.0001). Factors independently associated with raised serum AFP in patients with cirrhosis were female gender, black race, decreased platelet count, increased serum AST/ALT ratio, serum ferritin, and Mallory bodies in liver biopsies. Serum AFP levels decreased significantly during therapy with pegylated interferon alpha-2a and ribavirin. HCC was identified in six subjects, only three of whom had AFP > 20 ng/mL.

Conclusions: Among patients with advanced chronic hepatitis C, serum AFP values are frequently elevated, even in the absence of HCC. Factors associated with raised AFP include severity of liver disease, female gender and black race. Serum AFP levels decline during antiviral therapy.

PubMed Disclaimer

Publication types